Peter Janssens1,2, Karen Van Hoeve3, Liesbeth De Waele4,5, Stéphanie De Rechter4,3, Kathleen J Claes6,7, Els Van de Perre8, Karl Martin Wissing8, Bert Bammens6,7, Anna Jansen9, Djalila Mekahli4,3. 1. Department of Nephrology, UZ Brussel, Laarbeeklaan 101, 1090, Jette, Belgium. peter.janssens@uzbrussel.be. 2. Department of Development and Regeneration, KU Leuven, Leuven, Belgium. peter.janssens@uzbrussel.be. 3. Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium. 4. Department of Development and Regeneration, KU Leuven, Leuven, Belgium. 5. Department of Pediatric Neurology, University Hospitals Leuven, Leuven, Belgium. 6. Department of Microbiology & Immunology, KU Leuven, Leuven, Belgium. 7. Department of Nephrology, Dialysis and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium. 8. Department of Nephrology, UZ Brussel, Laarbeeklaan 101, 1090, Jette, Belgium. 9. Pediatric Neurology Unit, Department of Pediatrics, UZ Brussel, Brussel, Belgium.
Abstract
BACKGROUND: Renal pathology in tuberous sclerosis complex (TSC) is characterized by the growth of angiomyolipoma and renal cysts, and in rare cases renal cell carcinoma. Other consequences of renal involvement in TSC, including hypertension, proteinuria, and hyperfiltration, are not well studied. We aimed to analyze the early manifestations of the renal TSC phenotype in a young TSC cohort and to explore common, modifiable risk factors. METHODS: In this retrospective cohort study, TSC patients attending the TSC clinics of two tertiary hospitals were included. Data on demographics, history, genotype, kidney function, hematuria, proteinuria, blood pressure, and renal imaging were collected. RESULTS: Eighty patients were included, with a median age of 0.8 years (0.0-63.0) at first presentation, and a median follow-up time of 10.2 (0.4-41.0) years. Mutation analysis was available in 64 patients (80%). Renal lesions (cysts or angiomyolipoma) were observed in 55/73 (75%). Thirty-two percent (19/60) were hypertensive, 8/51 (16%) had proteinuria, and 18/71 (25%) had hyperfiltration (median eGFR 154 ml/min/m2). Six (7.5%) patients had developed end stage renal disease at the last follow-up. No association was found between hyperfiltration, hypertension, or proteinuria and CKD ≥ 3. Cox regression showed a significant positive association between the presence of a renal intervention and CKD ≥ 3 (Hazard-Ratio 3.91, P < 0.05). CONCLUSIONS: Besides renal cysts and angiomyolipoma, the modifiable progression factors hypertension, proteinuria, and hyperfiltration occur frequently and early in TSC patients. This represents a preventive treatment target.
BACKGROUND: Renal pathology in tuberous sclerosis complex (TSC) is characterized by the growth of angiomyolipoma and renal cysts, and in rare cases renal cell carcinoma. Other consequences of renal involvement in TSC, including hypertension, proteinuria, and hyperfiltration, are not well studied. We aimed to analyze the early manifestations of the renal TSC phenotype in a young TSC cohort and to explore common, modifiable risk factors. METHODS: In this retrospective cohort study, TSC patients attending the TSC clinics of two tertiary hospitals were included. Data on demographics, history, genotype, kidney function, hematuria, proteinuria, blood pressure, and renal imaging were collected. RESULTS: Eighty patients were included, with a median age of 0.8 years (0.0-63.0) at first presentation, and a median follow-up time of 10.2 (0.4-41.0) years. Mutation analysis was available in 64 patients (80%). Renal lesions (cysts or angiomyolipoma) were observed in 55/73 (75%). Thirty-two percent (19/60) were hypertensive, 8/51 (16%) had proteinuria, and 18/71 (25%) had hyperfiltration (median eGFR 154 ml/min/m2). Six (7.5%) patients had developed end stage renal disease at the last follow-up. No association was found between hyperfiltration, hypertension, or proteinuria and CKD ≥ 3. Cox regression showed a significant positive association between the presence of a renal intervention and CKD ≥ 3 (Hazard-Ratio 3.91, P < 0.05). CONCLUSIONS: Besides renal cysts and angiomyolipoma, the modifiable progression factors hypertension, proteinuria, and hyperfiltration occur frequently and early in TSC patients. This represents a preventive treatment target.
Authors: Joseph T Flynn; David C Kaelber; Carissa M Baker-Smith; Douglas Blowey; Aaron E Carroll; Stephen R Daniels; Sarah D de Ferranti; Janis M Dionne; Bonita Falkner; Susan K Flinn; Samuel S Gidding; Celeste Goodwin; Michael G Leu; Makia E Powers; Corinna Rea; Joshua Samuels; Madeline Simasek; Vidhu V Thaker; Elaine M Urbina Journal: Pediatrics Date: 2017-08-21 Impact factor: 7.124
Authors: Rebecca Hanratty; Michel Chonchol; Edward P Havranek; J David Powers; L Miriam Dickinson; P Michael Ho; David J Magid; John F Steiner Journal: Clin J Am Soc Nephrol Date: 2011-09-15 Impact factor: 8.237
Authors: Francis Vekeman; Matthew Magestro; Paul Karner; Mei Sheng Duh; Timothy Nichols; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Bernard A Zonnenberg Journal: J Med Econ Date: 2015-08-26 Impact factor: 2.448
Authors: Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer Journal: N Engl J Med Date: 2009-10-22 Impact factor: 91.245
Authors: Florian Grahammer; Suresh K Ramakrishnan; Markus M Rinschen; Alexey A Larionov; Maryam Syed; Hazim Khatib; Malte Roerden; Jörn Oliver Sass; Martin Helmstaedter; Dorothea Osenberg; Lucas Kühne; Oliver Kretz; Nicola Wanner; Francois Jouret; Thomas Benzing; Ferruh Artunc; Tobias B Huber; Franziska Theilig Journal: J Am Soc Nephrol Date: 2016-06-13 Impact factor: 10.121
Authors: Humphrey Mapuranga; Bianca Douglas-Jones; Danelo du Plessis; Camilla E le Roux; Christel du Buisson; Shahida Moosa Journal: SA J Radiol Date: 2022-05-20
Authors: Piotr Skrzypczyk; Anna Maria Wabik; Michał Szyszka; Sergiusz Józwiak; Przemysław Bombiński; Aleksandra Jakimów-Kostrzewa; Michał Brzewski; Małgorzata Pańczyk-Tomaszewska Journal: Front Pediatr Date: 2021-11-29 Impact factor: 3.418